| Old Articles: <Older 52981-52990 Newer> |
|---|
 |
The Motley Fool
October 28, 2011
Keki Fatakia |
Polycom Hits Rough Weather Polycom falls below expectations even after 23% increase in revenue.   |
The Motley Fool
October 28, 2011
Brian Orelli |
Invest in Biotechs Going After Unmet Needs What a quarter it was for Vertex Pharmaceuticals: $420 million in net sales of its new hepatitis C drug. |
The Motley Fool
October 28, 2011
Neha Chamaria |
Time to Stop Ignoring This Stock Caterpillar's record-high revenues tell a lot about its future. |
The Motley Fool
October 28, 2011
Alex Dumortier |
7 Stocks Ready to Outperform Will you be ready for the big reversal? |
The Motley Fool
October 28, 2011
Anders Bylund |
How to Invest in 4G Networks and Still Sleep at Night MIPS dips its chips into the oncoming torrent of LTE phones. |
The Motley Fool
October 28, 2011
John Grgurich |
3 Strong Yields From the Market's Biggest and Best Companies Sustainable dividends from companies you can count on to stick around: Proctor & Gamble... Coca-Cola... Diageo... |
The Motley Fool
October 28, 2011
Anders Bylund |
Computer Programs & Systems' Shares Got Crushed: What You Need to Know Is this meaningful? Or just another movement for Computer Programs & Systems? |
The Motley Fool
October 28, 2011
Anders Bylund |
Impressive Moves, LSI! The chip vendor moves into hot new markets without missing a beat. |
The Motley Fool
October 28, 2011 |
A Brief History of UnitedHealth's Returns UnitedHealth's stock has been a strong performer, but not as strong as it should have been given 24% annual earnings growth. Why? This chart explains it. |
The Motley Fool
October 28, 2011
Isac Simon |
How Valuable Is Northern Oil & Gas? Northern Oil & Gas appears to be intriguing. The third-quarter results should give a clearer picture. |
| <Older 52981-52990 Newer> Return to current articles. |
